Financial Results for June 30, 2013
Panacea Biotec Ltd has informed BSE about the Financial Results for the period ended June 30, 2013.08-08-2013
08-08-2013
Outcome of Board Meeting
Panacea Biotec Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, in view of non-availability of profits, has not recommended any dividend on the Equity Shares of the Company for the financial year ended March 31, 2013.30-05-2013
Financial Results & Auditors Report for March 31, 2013 (Audited)
Panacea Biotec Ltd has informed BSE about the Financial Results & a copy of the Auditors Report for the period ended March 31, 2013.30-05-2013
Press Release - Facts Related to Pentavalent Vaccine
Panacea Biotec Ltd has informed BSE regarding a Press Release dated May 21, 2013 titled "Facts Related to Pentavalent Vaccine"21-05-2013
Board to consider Dividend
Panacea Biotec Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2013, inter alia, to consider and approve the Audited Financial Results for the Financial Year 2012-13 and also consider the matter pertaining to passing over of dividend.10-05-2013
Updates on Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
Ravinder Jain has now submitted the updates on disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 201114-03-2013
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
Ravinder Jain has submitted the disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Reg. 201108-03-2013
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Panacea Biotec Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199221-02-2013
Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Soshil Kumar Jain has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 199221-02-2013